NEUROCOV

The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV


Description

Infections with the coronavirus SARS-CoV-2 can trigger both temporary and long-term neurological and neuropsychiatric symptoms, severely impacting patients and the wider society. The presently limited insights into COVID-19 and its underlying mechanisms – especially regarding our understanding of how the central nervous system is affected – restrict therapeutic possibilities. The new research project NEUROCOV will address this major unmet need by focusing on the interplay between the nervous tissue and the immune/inflammatory response triggered by SARS-CoV-2 infection. The project pursues a multi-scalar approach that reaches from epidemiology and mechanistic interrogation of host/virus interplay at single-cell resolution through predictive modelling all the way to validation of biomarkers and repurposed drugs. The aim is to anticipate and effectively manage personalized trajectories of NeuroCOVID vulnerability and their impact at population level. NEUROCOV will pioneer innovative robotics to scale brain organoid modelling and combine it with single-cell multiOMICs and AI analytics to dissect the principles of the individual host response and render experimentally actionable the authentic genetic backgrounds of differential SARSCoV-2 sensitivity.

Coordinator
Prof. Joachim Schultze
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V.
Email
Programme
Horizon Europe & sub-programmes
Duration
60 months (September 2019 - August 2024)
Project funding
€ 8,384,036.00
Project partners
10
Technology readiness level
2-4
Project website
https://www.neurocov.eu
Download Factsheet
Your contact
Laura Schweigert
Project Manager
Phone: +49 30 374415846
E-mail
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email